Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 1 filers reported holding Santen Pharmaceutical Co Ltd in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHUMBLINE ADVISERS | 30 | $273 | 0.00% |
External links
This page lists Santen Pharmaceutical Co Ltd's shareholders in Q3 2023. To view Santen Pharmaceutical Co Ltd's shareholder history, click here.